Protection by oral phenylalanine against gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. by Iishi, H. et al.
Br. J. Cancer (1990), 62, 173 176 t. Macmillan Press Ltd., 1990
Protection by oral phenylalanine against gastric carcinogenesis induced by
N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats
H. Tishi', M. Tatsuta', M. Babal, S. Okuda2 & H. Taniguchi3
Departments of 'Gastrointestinal Oncology, 2Gastroenterology, and 3Pathology, The Center for Adult Diseases, Osaka, 3-3
Nakamichi 1-chome, Higashinari-ku, Osaka 537, Japan.
Summary The effect of oral administration of L-phenylalanine on the incidence and histology of gastric
adenocarcinomas induced by N-methyl-N'-nitro-N-nitrosoguanidine was investigated in inbred Wistar rats.
Oral administration of 6% phenylalanine after 25 weeks of treatment with the carcinogen significantly reduced
the incidence and number of adenocarcinomas of the glandular stomach at experimental week 52. Oral
administration of high dose phenylalanine significantly increased the basal serum gastrin level and significantly
decreased the norepinephrine concentration in the antral portion of the gastric wall, as well as the labelling
indices of antral mucosa. These findings indicate that orally administered phenylalanine inhibits the develop-
ment of gastric cancers.
Gastrointestinal regulatory peptides, such as vasoactive intes-
tinal peptide (lishi et al., 1987), secretin (Howatson & Carter,
1987), cholecystokinin and its analogue (Satake et al., 1986),
and gastrin (Tatsuta et al., 1977b), have been found to
regulate development of cancers of the gastrointestinal tract
and the pancreas. We recently found that prolonged
alternate-day administration of the potent duodenal
ulcerogen cysteamine after 25 weeks of N-methyl-N'-nitro-N-
nitrosoguanidine (MNNG) treatment led to marked hyper-
gastrinaemia and also to significant protection against the
development of gastric cancers (Tatsuta et al., 1988a). These
findings indicate that exogenous and endogenous gastrin may
be closely associated with gastric carcinogenesis.
Of all the gastrointestinal regulatory peptides, the antral
hormone gastrin has been most extensively studied. Food
plays an important role in the regulation of serum and tissue
gastrin levels. Lichtenberger et al. (1982) reported that of the
amino acids, L-phenylalanine (phenylalanine) has a strong
stimulatory action on gastrin release. These findings suggest
that phenylalanine should inhibit gastric carcinogenesis.
Therefore, to test this possibility in the present work we
examined the effect of oral administration of phenylalanine
on the incidence, number, and histological appearance of
adenocarcinomas in rats induced by MNNG.
Materials and methods
Animals
Young male Wistar rats (n = 60), aged about 6 weeks, were
purchased from SLC, Japan (Shizuoka, Japan). The rats were
housed in suspended wire-bottomed metal cages in animal
quarters with controlled temperature (21-22°C), humidity
(30-50%), and light (12-h cycle), and had free access to
chow pellets (Oriental Yeast, Tokyo, Japan).
Experimental design
The animals were given drinking water containing MNNG
(50fgml-'; Aldrich Chemical, Milwaukee, WI) for 25
weeks. The MNNG was dissolved in deionised water at a
concentration of 2 mg ml' and was kept in a cool, dark
place. The stock solution was diluted to 50pg ml-' with tap
water just before use. Forty ml of MNNG solution (less than
a given rat consumes in 48 h) was given to each rat from
bottles covered with aluminium foil to prevent denaturation
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of the MNNG by light. The bottles were replenished every
other day.
Beginning with experimental week 26, the MNNG-treated
rats were given normal tap water. They were divided into two
groups, which were treated until the end of the experiment at
week 52 as follows: group 1 (30 rats) were given regular
laboratory chow pellets containing 1% phenylalanine ad
libitum; group 2 (30 rats) received 6% phenylalanine orally.
Phenylalanine (Sigma Chemical, St Louis, MO) was added to
regular chow pellets and given ad libitum until the end of the
experiment. The chow pellets, with or without added
phenylalanine, were given in isocaloric amounts
(60 kcal day-').
Histological observation
Animals that survived for more than 50 experimental weeks
were included in the effective numbers because the first
tumour of the glandular stomach was found in a rat in group
1 which died in week 50. Animals were sacrificed when they
became moribund during the experiment or at the end of
experimental week 52. All animals were autopsied, and the
stomach and other organs were carefully examined. The
stomach was opened, pinned flat on a cork mat, and fixed
with Zamboni's solution (Stefanini et al., 1967) for his-
tological examination. Longitudinal strips 3 mm wide were
prepared from visible tumours and suspicious lesions. The
specimens were then embedded in paraffin, and sections 5gtm
thick were stained with hematoxylin and eosin. In addition to
tumours, flat mucosa from the fixed stomach with no visible
tumours was cut into strips 3 mm wide, and serial sections
were examined microscopically for foci of malignant cells.
The sections were examined without knowledge of which
group they were from.
Definition andclassification ofgastric cancers
We defined adenocarcinomas as lesions in which neoplastic
cells had penetrated the muscularis mucosae to involve the
submucosa or deeper layers. As previously reported (Tatsuta
et al., 1988b), adenocarcinomas were classified as follows. (1)
Highly well-differentiated adenocarcinomas: cancers showing
atypical glandular structure with a tubular or papillary pat-
tern and an arrangement of cells comparable to that enclos-
ing normal gastrointestinal crypts, but adenocarcinomas in
which these glands involved the muscularis mucosae. (2)
Well-differentiated adenocarcinomas: (a) common type; less
differentiated glands, consisting of disorderly arranged
atypical cells containing intracellular mucin; (b) mucinous
carcinomas; active mucin secretion, often resulting in
mucinous nodules with a large amount of extracellular
mucin, with only a few isolated groups of tumour cells. (3)
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Poorly differentiated adenocarcinomas: (a) anaplastic car-
cinoma; individual, scattered highly anaplastic cells without
any typical glandular or tubular differentiation; (b) signet
ring cell carcinoma; tumour cells containing large amounts of
intracellular mucin, giving the cells a signet ring appearance.
Labelling indices ofgastric mucosa
The labelling indices of gastric mucosa were measured at
weeks 30 and 52 with an immunohistochemical analysis kit
for assaying bromodeoxyuridine (BrdU) incorporation
(Gratzner, 1982; Morstyn et al., 1983) (Becton-Dickinson
Immunocytometry System, Mountain View, CA), by the
modified method described by Tada et al. (1985). Briefly, 5
rats from each group were fasted for 12 h and then re-fed ad
libitum on chow pellets, with or without added
phenylalanine, for 1 h. Then the rats received an i.p. injection
of BrdU (20 mg kg-' body weight) and were sacrificed with
ether after one more hour. The stomach was fixed in 70%
ethanol for 4 h. Sections 3 pm thick were immersed in
2 N HCI solution for 30 min at room temperature and then in
0.1 M Na2B407 to neutralise the acid. The sections were then
stained with anti-BrdU monoclonal antibody (diluted 1:100)
for 2 h at room temperature, washed, stained with biotin-
conjugated horse anti-mouse antibody (at a dilution of 1:200)
for 30 min, and stained with avidin-biotin-peroxidase com-
plex for 30 min. The reaction product was localised with
3,3'-diaminobenzidine tetrahydrochloride. Cells containing
BrdU were identified by the presence of dark pigment over
their nuclei.
For analysis of the labelling indices, the numbers of BrdU-
labelled cells were counted without knowledge of which treat-
ment they.had undergone. The average number of glands
examined in each rat was 137. The labelling index was exp-
ressed as the number of labelled nuclei per gland (Tatsuta et
al., 1988b).
Measurement ofnorepinephrine and epinephrine in gastric wall
tissue
Norepinephrine and epinephrine concentrations in tissues of
the gastric wall were determined at week 52 by high-
performance liquid chromatography as previously reported
(Tatsuta et al., 1983). For this, 8 non-fasted rats from each
group were killed with an overdose of ether, and a sample of
about 50 mg of gastric wall was obtained from the fundic
and antral portions of the stomach of each rat. The samples
were homogenated with 4.0 ml of 0.4 N perchloric acid and
centrifuged at 2,500 r.p.m. for 10 min. The supernatant was
mixed with 1.0 ml of 0.2 M disodium ethylendiamine tetra-
acetate (EDTA), and the mixture was adjusted to pH 6.0
with ammonium hydroxide. This mixture was then added to
300 mg of purified alumina (Woelm Neutral Active Grade I)
following the method described by Anton and Sayre (1962),
and the pH was adjusted to 8.4-8.8 with ammonium hydro-
xide. The mixture was stirred for 5 min and centrifuged at
10,000 g for Omin, and the supernatant was aspirated and
discarded. The precipitated aluminium was washed twice
with distilled water and was then shaken vigorously with
2.5 ml of 0.4 N acetate. After centrifugation of this mixture,
the clear supernatant was transferred to a small glass tube
and lyophilised for 3 h. The residue was dissolved in 0.5 ml
of 0.2 N acetic acid, and a 50 .l aliquot of this solution was
injected into a liquid chromatographic column (Hitachi 3011-
C gel column, 2.6 x 250mm). Materials were eluted with
0.1 M KH2PO4 containing 0.05% H3PO4 at a constant flow of
0.5 ml min-' at 45.0 ± 0.2°C. The effluent was mixed with the
reagent for the trihydroxyindole reaction, which contained
0.0075% potassium ferricyanide, 0.1% ascorbic acid, and 5 N
sodium hydroxide. The resulting fluorescent products were
examined with a highly sensitive spectrofluorophotometer.
AntralpH and serum gastrin levels
Antral pH and serum gastrin levels in the fasting state and
after re-feeding were determined at experimental week 52. Six
rats from each group were fasted for 12 h and then anaesthe-
tised. Blood was obtained by cardiac puncture, and the pH
of the antral mucosa was measured with a fine pH electrode
after the stomach was opened along the greater curvature. A
different set of 6 rats from each group was used for measure-
ment of the serum gastrin response to re-feeding and the
antral pH after re-feeding. For this, the rats were fasted for
12 h and then re-fed ad libitum on chow pellets, with or
without added phenylalanine, for 30 min, after which they
were anaesthetised and blood was obtained by cardiac punc-
ture. The pH of the antral mucosa was also measured after
removal of the gastric contents. The serum was separated
and stored at - 20°C, and within 1 week its gastrin content
was assayed with a radioimmunoassay kit from Dainabott
Radioisotope Laboratories (Tokyo, Japan) (Tatsuta et al.,
1977a).
Statistical analysis
Results were analysed by the x2 test, Fisher's exact prob-
ability test (Siegel, 1956) or by Student's t test (Snedecor &
Cochran, 1967). Data are given as means ± s.e. 'Significant'
indicates a calculated P value of less than 0.05.
Results
Incidence, number, and histological types ofgastric cancers
No rats died before week 50. One rat in each group died
during weeks 50 and 51, and these animals were included in
the effective numbers. At week 52, all rats that had received
high-dose phenylalanine had slightly but not significantly
greater body weights than those of the control group.
The incidence and number of gastric cancers in each group
are summarised in Table I. In group 1 (MNNG alone),
gastric cancers were found in 18 (72%) of the 25 rats; the
average number of gastric cancers was 0.8 ± 0.1 per rat. The
incidence and number of gastric cancers per rat were
significantly lower in group 2 (MNNG + phenylalanine). All
cancers were found in the antral mucosa, and no metastases
were seen in any rats.
All tumours induced in the glandular stomach were adeno-
carcinomas. In group I (MNNG alone), 21 cancers induced
were all highly-well differentiated. In group 2 (MNNG +
phenylalanine), the incidence of highly-well differentiated
adenocarcinomas was significantly lower than that in group
1: 7 of 11 cancers induced were well differentiated. However,
Table I Incidence and number of gastric cancers in MNNG-treated rats
Body weight(g) Effective No. ofrats No. ofgastric Group no. of with gastric cancersper
no. Treatmenta Week 26 Week 52 rats cancers (%) rat
I MNNG alone 336±4b 403± 5 25 18 (72) 0.8±0.1
2 MNNG + 338±5 412±4 25 9 (36)Y 0.4±0.lc
phenylalanine
aTreatment regimens: MNNG alone, 50 lAg MNNG ml-' was given in the drinking
water for 25 weeks, followed by regular chow pellets; MNNG + phenylalanine, chow
pellets to which 5% phenylalanine was added were given after 25 weeks of MNNG
treatment. bMeans±s.e. cSignificantly different from the value for group I at P<0.05.PHENYLALANINE PROTECTION AGAINST GASTRIC CANCER 175
no poorly differentiated cancers were found in any of the
groups. The depth of involvement of the gastric cancers did
not differ between the two groups.
Tissue norepinephrine and labelling index
Table II summarises data on the labelling index of the gastric
mucosa in each group at weeks 30 and 52. At both times, the
labelling index of antral mucosa for group 2 (MNNG +
phenylalanine) was significantly lower than in group 1
(MNNG alone). However, oral administration of phenyla-
lanine had no influence on the labelling index of fundic
mucosa.
Tissue norepinephrine, antralpH and serum gastrin levels
Table III summarises the data for each group on norepine-
phrine concentrations in the gastric walls, the antral pH and
serum gastrin levels in the fasting state and after re-feeding in
week 52. Tissue norepinephrine concentrations in the antral
portion of the gastric walls for group 2 (MNNG + pheny-
lalanine) were significantly lower than in group 1 (MNNG
alone). However, phenylalanine did not affect norepinephrine
concentrations of the fundic portion. In this experiment,
epinephrine was not found in any samples obtained from
gastric walls. Oral administration of high dose phenylalanine
in group 2 caused a significant increase in the basal serum
gastrin level as compared with that in group 1. However, it
did not affect the antral pH in the fasting state or after the
re-feeding, nor did it affect the serum gastrin level in res-
ponse to re-feeding.
Discussion
The trophic effects of gastrin on epithelial cells of the fundic
mucosa has been well established (Johnson, 1977). However,
studies on the effects of gastrin on antral mucosal cells have
provided conflicting results. Pentagastrin has not been
observed to stimulate DNA synthesis in the antral mucosa of
rats, nor has gastrin been shown to increase the synthesis of
protein in this tissue (Johnson, 1977). On the contrary,
Casteleyn et al. (1977) found that pentagastrin inhibited nor-
mal cell proliferation in the antral mucosa of rats. We
previously found that prolonged administration of tetragast-
rin in depot form after MNNG treatment significantly
reduced the incidence of gastric cancer and the labelling
index of the antral mucosa. We suggested that the inhibitory
effect of tetragastrin on gastric carcinogenesis is related to its
effect in decreasing proliferation of the antral mucosa cells
(Tatsuta et al., 1988b). In the present work, we found that
prolonged administration of phenylalanine led to an endo-
genous hypergastrinaemia and also to a significant decrease
in the labelling index of the antral mucosa. These findings
indicate that the hypergastrinaemia and the subsequent
decrease of the labelling index of the antral mucosa may be
related to the inhibition by phenylalanine of gastric car-
cinogenesis.
Several diseases are known to be associated with elevated
serum levels of an amino acid. In phenylketonuria, lack of
the liver enzyme phenylalanine hydroxylase results in ele-
vated serum levels of phenylalanine, leading to brain damage
and mental retardation (Davison, 1973). Englesberg et al.
(1976) have demonstrated that phenylalanine is a potent
inhibitor of growth of several mammalian cell lines. Johnson
and Shah (1984) studied DNA synthesis and degradation in
brain to investigate the effects on cell proliferation and
naturally occuring cell death of hyperphenylalaninaemia
induced in rats by treatment with p-chlorophenyl and phenyl-
alanine during suckling. These authors found that the treat-
ment reduced DNA synthesis in cerebrum of 11-day-old rats.
Dillehay et al. (1980) found that phenylalanine at high con-
centrations inhibits the growth of mouse A9 cells, is a potent
inhibitor of protein synthesis, and decreases the initial rate of
uptake and the steady-state levels of several amino acids.
They suggested that this phenylalanine inhibition does not
appear to result from a deficiency of amino acid, but rather
is due to the high intracellular phenylalanine concentration
and/or to an amino acid imbalance resulting from the large
ratio of phenylalanine to other amino acids.
Via its hydroxylation to tyrosine, phenylalanine is a cate-
cholamine precursor. Synthesis of the catecholamine neuro-
transmitters dopamine and norepinephrine requires the trans-
port of their amino acid precursor, L-tyrosine. However, the
uptake of tyrosine is competitive with that of other large
neutral amino acids, such as valine, leucine and tryptophan
(Wurtman et al., 1974). Phenylalanine loading competitively
inhibits tyrosine transport (Dillehay et al., 1980; Wirz-Justice,
1977). Phenylketonuria is associated with very high levels in
plasma and brain but with large reductions in neuronal
stores of tyrosine, dopamine and norepinephrine (McKean,
1972). Wurtman et al. (1974) also reported that high plasma
levels of competing amino acids, such as phenylalanine, can
suppress brain catecholamines. Similarly, in the present work,
we found that long-term oral administration of phenylalanine
led to a significant decrease in the norepinephrine concentra-
Table II Labelling indices ofgastric mucosa in MNNG-treated rats
Experi- No. of Labelling index (nuclei per gland)
ental Group rats
week no. Treatmenta examined Fundic mucosa Antral mucosa
30 1 MNNG alone 5 1.49±0.14 3.66±0.21b
2 MNNG + 5 1.52±0.19 3.06±0.16c
phenylalanine
52 1 MNNG alone 5 1.32±0.08 2.67±0.16
2 MNNG + 5 1.31±0.08 2.04±0.2Id
phenylalanine
aForexplanation oftreatments, seeTableI. bMeans± s.e.C.d.Significantly different from
the value for group 1: CP<0.02; dp<0.05.
Table III Norepinephrine concentration in the gastric wall, antral pH and serum gastrin levels in
MNNG-treated rats
Norepinephrine Serum gastrin
concentration (ngg' tissue) AntralpH (pgm-1)
Group Fundic Antral After After
no. Treatmenta portion portion Fasting re-feeding Fasting re-feeding
1 MNNG alone 487.30±23.88b 364.03±24.37 3.4±0.2 4.1 ±0.2 427± 14 403±5
2 MNNG + 487.39±44.06 331.70±31.31c 3.5±0.2 3.6±0.2 549±31c 412±4
phenylalanine
aForexplanation oftreatments, seeTableI. bMeans± s.e.cSignificantly different from thevalueforgroup
1 at P<0.02.176 H. IISHI et al.
tion in the gastric wall.
Catecholamines have the ability to influence proliferation
of a wide variety of cells. Norepinephrine released by actions
of the sympathetic nervous system appears to stimulate crypt
cell proliferation in.both small and large intestine but not in
colon tumours (Tutton & Helme, 1974; Tutton & Barkla,
1977). We recently found that the incidence and number of
gastric cancers induced by MNNG were significantly greater
in spontaneously hypertensive rats than in normotensive rats.
In these animals, the norepinephrine concentration in gastric
wall and the labelling index of gastric mucosa were
significantly higher as compared with those for normotensive
rats (Tatsuta et al., 1989).
The present results show that feeding of 6% phenylalamnne
reduced the incidence and number of gastric cancers. How-
ever, the depth ofinvolvement ofgastric cancer did not differ
between the two groups. This indicates that administration of
high dose phenylalanine suppresses the development of gast-
ric cancers, but does not affect the growth of gastric cancers.
Although the exact mechanism of this effect of phenylalanine
is still unclear, these findings indicate that oral phenylalanine
inhibits the development of gastric cancers, and that its
suppression of the labelling index of antral mucosa may be
related to inhibition of gastric carcinogenesis.
References
ANTON, A.H. &SAYRE, D.F. (1962). A study ofthe factors affecting the
aluminum oxide-trihydroxyindole procedure for the analysis of
catecholamines. J. Pharmacol. Exp. Ther., 138, 360.
CASTELEYN, P.P., DUBRASQUET, M. &WILLEMS, G. (1977). Opposite
effects ofgastrin on cell proliferation in the antrum and other parts
of the upper-gastrointestinal tract in the rat. Dig. Dis., 22, 798.
DAVISON, A.N. (1973). Myelination of the central nervous system. In
Inborn Errors ofMetabolism, Hommers, F.A. & Van den Berg, C.J.
(eds) p. 55. Academic Press: New York.
DILLEHAY, L., BASS, R. & ENGLESBERG, E. (1980). Inhibition of
growth ofcells in culture by l-phenylalanine as a model system for
the analysis ofphenylketonuria. I. Amino acid antagonism and the
inhibition of protein synthesis. J. Cell. Physiol., 102, 395.
ENGLESBERG, E., BASS, R. & HEISER, W. (1976). Inhibition of the
growth of mammalian cells in culture by amino acids and the
isolation and characterization ofl-phenylalanine-resistant mutants
modifying I-phenylalanine transport. Somat. Cell Genet., 2, 411.
GRATZNER, H.G. (1982). Monoclonal antibody to 5-bromo- and
5-iododeoxy-uridine: a new reagent for detection of DNA replica-
tion. Science, 218, 474.
HOWATSON, A.G. & CARTER, D.C. (1987). Pancreatic carcinogenesis:
effectofsecretin on thenumberin thehamster-nitrosamine model. J.
Natl Cancer Inst., 78, 101.
IISHI, H.,TATSUTA, M., BABA, M.,OKUDA, S. &TANIGUCHI, H. (1987).
Enhancement by vasoactive intestinal peptide of experimental
carcinogenesis induced by azoxymethane in rat colon. Cancer Res.,
47, 4890.
JOHNSON, L.R. (1977). Newaspectsofthe trophicactionofgastrointes-
tinal hormones. Gastroenterology, 72, 788.
JOHNSON, R.C. & SHAH, N. (1984). Effect of hyperphenylalaninemia
induced during suckling on brain DNA metabolism in rat pups.
Neurochem. Res., 9, 517.
LICHTENBERGER, L.M., DELANSORNE, R. & GRAZIANI, L.A. (1982).
Importance of amino acid uptake and decarboxylation in gastrin
release from isolated G cells. Nature, 295, 698.
MCKEAN, C.M. (1972). Theeffects ofhigh phenylalanineconcentrations
on serotonin and catecholamine metabolism in the human brain.
Brain Res., 47, 469.
MORSTYN,G.,HSU,S.-M.,KINSELLA,T.&3others(1983). Bromodeox-
yuridine in tumors and chromosomes detected with a monoclonal
antibody. J. Clin. Invest., 72, 1844.
SATAKE, K., MUKAI, R., KATO, Y. & UMEYAMA, K. (1986). Effects of
cerulein on the normal pancreas and on experimental pancreatic
carcinoma in the Syrian golden hamster. Pancreas, 1, 246.
SIEGEL, S. (1956). Nonparametric Statisticsfor the Behavioral Sciences.
McGraw-Hill: New York.
SNEDECOR, G.W. &COCHRAN, W.G. (1967). Statistical Methods. Iowa
State University Press: Ames, IA.
STEFANINI, M., DE MARTINO, C. & ZAMBONI, L. (1967). Fixation of
ejaculated spermatozoa for electron microscopy. Nature, 216, 173.
TADA, T., KODAMA, T., WATANABE, S., SATO, Y. & SHIMOSATO, Y.
(1985). Cell kinetics studies by the use of anti-bromodeoxyuridine
monoclonal antibodyand theirclinicalapplication. Igaku-no-ayumi,
135, 510.
TATSUTA, M., BABA, M. & ITOH, T. (1983). Increased gastrin secretion
in patients with pheochromocytoma. Gastroenterology, 84, 920.
TATSUTA, M., IISHI, H., BABA, M. & TANIGUCHI, H. (1989). Enhance-
ment of experimental gastric carcinogenesis induced in spon-
taneously hypertensive rats by N-methyl-N'-nitro-N-
nitrosoguanidine. Cancer Res., 49, 794.
TATSUTA, M., ITOH, T., OKUDA, S., TAMURA, H. & YAMAMURA, H.
(1977a). Effects offundusectomy on serum and antral gastrin levels
in rats. Gastroenterology, 72, 78.
TATSUTA, M., ITOH, T., OKUDA, S., TANIGUCHI, H. & TAMURA, H.
(1977b). Effect of prolonged administration of gastrin on experi-
mentalcarcinogenesisin ratstomach induced byN-methyl-N'-nitro-
N-nitrosoguanidine. Cancer Res., 37, 1808.
TATSUTA, M., IISHI, H.,YAMAMURA, H.&3 others(1988a). Inhibitory
effect of prolonged administration of cysteamine on experimental
carcinogenesis in rat stomach induced by N-methyl-N'-nitro-N-
nitrosoguanidine. Int. J. Cancer, 41, 423.
TATSUTA, M., IISHI, H., YAMAMURA, H. & 3 others (1988b). Effect of
cimetidine oninhibition bytetragastrin ofcarcinogenesis induced by
N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Cancer Res.,
48, 1591.
TUTTON, P.J.M. &BARKLA, D.H. (1977). Theinfluenceofadrenoceptor
activity on cell proliferation in colonic crypt epithelium and in
colonic adenocarcinoma. Virchows Arch. (Cell Pathol.), 24, 139.
TUTTON, P.J.M. & HELME, R.D. (1974). The influence ofadrenoceptor
activity on crypt cell proliferation in the rat jejunum. Cell Tissue
Kinet., 7, 125.
WIRZ-JUSTICE, A. (1974). Theoretical and therapeutic potential of
indoleamine precursors in affective disorders. Neuropsychobiology,
3, 199.
WURTMAN, R.J., LARIN, F., MOSTAFAPOUR, S. & FERNSTOM, JD.
(1974). Brain catechol synthesis: control by brain tyrosine concent-
ration. Science, 185, 183.